scholarly journals HEPARIN OR 0.9% SODIUM CHLORIDE TO MAINTAIN CENTRAL VENOUS CATHETER PATENCY: A RANDOMISED TRIAL

2014 ◽  
Vol 3 (01) ◽  
pp. 46-50 ◽  
Author(s):  
Mahesh Babu B.V. ◽  
A.S. Kameswara Rao ◽  
Rajesh K. ◽  
V. Harinath Babu
2012 ◽  
Vol 40 (6) ◽  
pp. 1820-1826 ◽  
Author(s):  
Marilyn E. Schallom ◽  
Donna Prentice ◽  
Carrie Sona ◽  
Scott T. Micek ◽  
Lee P. Skrupky

PLoS ONE ◽  
2015 ◽  
Vol 10 (6) ◽  
pp. e0130661 ◽  
Author(s):  
Giovanna Figueiredo ◽  
Teresa Fiebig ◽  
Stefanie Kirschner ◽  
Omid Nikoubashman ◽  
Lisa Kabelitz ◽  
...  

2018 ◽  
Vol 26 (0) ◽  
Author(s):  
Rafael Fernandes Bel Homo ◽  
Antônio Fernandes Costa Lima

ABSTRACT Objective: to identify the average direct cost of maintaining the patency of totally implanted central venous catheter with heparin at a Day Hospital of a public hospital of high complexity specialized in the treatment of cancer patients, and estimate the average direct cost of replacing heparin with sodium chloride 0.9%. Method: quantitative, exploratory-descriptive study, with a sample of 200 non-participant observations of the maintenance of totally implanted central venous catheters with heparin. The average direct cost was calculated by multiplying the (clocked) time spent by professionals to complete the procedure by the direct unit cost of workforce, added to the cost of materials and solutions. Results: the estimated total direct cost of catheter maintenance with heparin was US$ 9.71 (SD=1.35) on average, ranging from US$ 7.98 to US$ 23.28. The estimated total direct cost of maintenance with 0.9% sodium chloride in the place of heparin was US$ 8.81 (SD=1.29) on average, resulting in a reduction of US$ 0.90 per procedure. Conclusion: the results contributed to propose strategies to assist in cost containment/minimization in this procedure. The replacement of heparin by 0.9% sodium chloride proved to be an option to reduce the total average direct cost.


PeerJ ◽  
2019 ◽  
Vol 7 ◽  
pp. e7072
Author(s):  
Julieann Vose ◽  
Adesola Odunayo ◽  
Joshua M. Price ◽  
Maggie Daves ◽  
Julie C. Schildt ◽  
...  

Background The purpose of this study was to determine whether heparinized saline (HS) would be more effective in maintaining the patency of central venous catheters (CVCs) in dogs compared to 0.9% sodium chloride. This was a prospective randomized blinded study conducted at a University Veterinary Teaching Hospital. Methods A total of 24 healthy purpose-bred dogs were randomized into two groups: a treatment and a control group. A CVC was placed in the jugular vein of each dog. Each dog in the treatment group had their CVC flushed with 10 IU/mL HS, while dogs in the control group had their CVC flushed with 0.9% sodium chloride every 6 h for 72 h. Immediately prior to flushing, each catheter was evaluated for patency by aspiration of blood. The catheter site was also evaluated for phlebitis, and a rectal temperature was obtained in each dog every 6 h. Prothrombin (PT) and activated partial thromboplastin (aPTT) times were evaluated prior to the administration of any flush solution. Results were then compared to values obtained 72 h later. Results All CVCs in both groups were patent after 72 h, which was demonstrated by aspiration of blood and ease of flushing the catheter. Two CVCs in the 0.9% sodium chloride group had a negative aspiration at hour 12 and 36, respectively. One CVC in the HS group had a negative aspiration at hour 18. Signs of phlebitis occurred in three dog: two in the 0.9% sodium chloride group and one in the HS group. No dog was hyperthermic (>103 °F). Two catheters were inadvertently removed by dogs in the HS group during the study. There were no significant differences in catheter patency, incidence of phlebitis, or incidence of negative aspirations between both groups. aPTT and PT values remained within the normal reference range for all dogs in both groups. Ultimately, 0.9% sodium chloride was as effective as 10 IU/mL HS in maintaining the patency of CVCs for up to 72 h in healthy dogs. Further evaluation in clinical patients is warranted.


Sign in / Sign up

Export Citation Format

Share Document